Market Review: 11-13-20

By: Steven Doll, Portfolio Strategist

For the Week ending November 13th, 2020

The U.S. stock market jumped this week despite record high coronavirus cases as Pfizer reported very encouraging results for its COVID-19 vaccine. U.S. small-cap stocks outpaced U.S. large-cap stocks by over 2.5% as a vaccine would be of greater benefit for small companies than large companies. Developed markets also outpaced emerging markets on the week, yet are still underperforming emerging markets by over 5.5% year-to-date.

Interest rates also rose on Pfizer’s vaccine news as the 10-year treasury yield rose from 0.83% to 0.89%. Consequently, the U.S. bond market inched lower as prices have an inverse relationship with interest rates.

The price of gold fell 4.2% on the week as the positive news around Pfizer’s COVID-19 vaccine decreases the demand for the safe-haven metal. Meanwhile the COVID-19 vaccine news also increased the demand for crude oil, which rose nearly 5.0%

Year-to Date Return (as of 11/13/2020)

11 views0 comments

Recent Posts

See All

Waiting For The Inflation Canary To Sing… Or Not

By James Picerno, Director of Analytics The Federal Reserve reports that it expects faster economic growth and higher inflation – two factors that historically have triggered tighter monetary policy.

What Biden’s Tax Changes Might Mean for Investors

This past Wednesday, President Biden laid out the tax changes he is proposing to fund his most recent spending package, which he has named “The American Family Plan”. The $1.8 trillion dollar plan, wh

Desperately Seeking Yield: 20 April 2021

By James Picerno, Director of Analytics The recent rise in Treasury yields is on hold for the moment. So is the normally shifting sands of trailing yields for the various components of the major asset